Cargando…

Quality of life assessment among multiple sclerosis patients in Saudi Arabia

OBJECTIVES: To determine the quality of life (QoL) among multiple sclerosis (MS) patients in Kingdom of Saudi Arabia. METHODS: A cross-sectional study was carried out to assess the QoL of MS patients during the period from November 2016 to May 2017. Patients were recruited from tertiary hospitals in...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhazzani, Adel A., Alqahtani, Mohammed S., Alahmari, Mohammed S., Asiri, Muhannad A., Alamri, Noof M., Sarhan, Leen A., Alkhashrami, Shahad S., Asiri, Abdullmgeed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Riyadh : Armed Forces Hospital 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015454/
https://www.ncbi.nlm.nih.gov/pubmed/29664456
http://dx.doi.org/10.17712/nsj.2018.2.20170335
_version_ 1783673679167619072
author Alhazzani, Adel A.
Alqahtani, Mohammed S.
Alahmari, Mohammed S.
Asiri, Muhannad A.
Alamri, Noof M.
Sarhan, Leen A.
Alkhashrami, Shahad S.
Asiri, Abdullmgeed A.
author_facet Alhazzani, Adel A.
Alqahtani, Mohammed S.
Alahmari, Mohammed S.
Asiri, Muhannad A.
Alamri, Noof M.
Sarhan, Leen A.
Alkhashrami, Shahad S.
Asiri, Abdullmgeed A.
author_sort Alhazzani, Adel A.
collection PubMed
description OBJECTIVES: To determine the quality of life (QoL) among multiple sclerosis (MS) patients in Kingdom of Saudi Arabia. METHODS: A cross-sectional study was carried out to assess the QoL of MS patients during the period from November 2016 to May 2017. Patients were recruited from tertiary hospitals in 5 regions in the kingdom. Clinical and demographic data were collected and information on patients’ health status using the self-report SF-36 questionnaire to assess QoL. The Patient Determined Disease Steps (PDDS) was used to measure disability. Data were analyzed using descriptive statistics, the Mann–Whitney test, the Kruskal Wallis test and Spearman’s coefficient correlation. RESULTS: From the 598 MS patients studied, 384 (64.2%) were female. The mean score for males was higher than females in all SF-36 QoL subscales. The mean age was 32.4 years (SD=8.4). The mean duration of illness was 6.5 years. Patients had the lowest scores in role motioning/emotional scale (mean=42.6, SD=43.3). The PDDS was negatively correlated with all SF-36 QoL subscales. Self Report-36 QoL for MS patients differed significantly through demographic characteristics at a level of significance of 0.05. CONCLUSIONS: Multiple Sclerosis patients have a low QoL score and need more comprehensive management by their treating physicians. Further development of the registration will provide access to the entire population of MS patients and help comprehensively analyze the factors that affect the quality of their lives.
format Online
Article
Text
id pubmed-8015454
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Riyadh : Armed Forces Hospital
record_format MEDLINE/PubMed
spelling pubmed-80154542021-08-13 Quality of life assessment among multiple sclerosis patients in Saudi Arabia Alhazzani, Adel A. Alqahtani, Mohammed S. Alahmari, Mohammed S. Asiri, Muhannad A. Alamri, Noof M. Sarhan, Leen A. Alkhashrami, Shahad S. Asiri, Abdullmgeed A. Neurosciences (Riyadh) Original Article OBJECTIVES: To determine the quality of life (QoL) among multiple sclerosis (MS) patients in Kingdom of Saudi Arabia. METHODS: A cross-sectional study was carried out to assess the QoL of MS patients during the period from November 2016 to May 2017. Patients were recruited from tertiary hospitals in 5 regions in the kingdom. Clinical and demographic data were collected and information on patients’ health status using the self-report SF-36 questionnaire to assess QoL. The Patient Determined Disease Steps (PDDS) was used to measure disability. Data were analyzed using descriptive statistics, the Mann–Whitney test, the Kruskal Wallis test and Spearman’s coefficient correlation. RESULTS: From the 598 MS patients studied, 384 (64.2%) were female. The mean score for males was higher than females in all SF-36 QoL subscales. The mean age was 32.4 years (SD=8.4). The mean duration of illness was 6.5 years. Patients had the lowest scores in role motioning/emotional scale (mean=42.6, SD=43.3). The PDDS was negatively correlated with all SF-36 QoL subscales. Self Report-36 QoL for MS patients differed significantly through demographic characteristics at a level of significance of 0.05. CONCLUSIONS: Multiple Sclerosis patients have a low QoL score and need more comprehensive management by their treating physicians. Further development of the registration will provide access to the entire population of MS patients and help comprehensively analyze the factors that affect the quality of their lives. Riyadh : Armed Forces Hospital 2018-04 /pmc/articles/PMC8015454/ /pubmed/29664456 http://dx.doi.org/10.17712/nsj.2018.2.20170335 Text en Copyright: © Neurosciences https://creativecommons.org/licenses/by-nc-sa/3.0/Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.
spellingShingle Original Article
Alhazzani, Adel A.
Alqahtani, Mohammed S.
Alahmari, Mohammed S.
Asiri, Muhannad A.
Alamri, Noof M.
Sarhan, Leen A.
Alkhashrami, Shahad S.
Asiri, Abdullmgeed A.
Quality of life assessment among multiple sclerosis patients in Saudi Arabia
title Quality of life assessment among multiple sclerosis patients in Saudi Arabia
title_full Quality of life assessment among multiple sclerosis patients in Saudi Arabia
title_fullStr Quality of life assessment among multiple sclerosis patients in Saudi Arabia
title_full_unstemmed Quality of life assessment among multiple sclerosis patients in Saudi Arabia
title_short Quality of life assessment among multiple sclerosis patients in Saudi Arabia
title_sort quality of life assessment among multiple sclerosis patients in saudi arabia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015454/
https://www.ncbi.nlm.nih.gov/pubmed/29664456
http://dx.doi.org/10.17712/nsj.2018.2.20170335
work_keys_str_mv AT alhazzaniadela qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia
AT alqahtanimohammeds qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia
AT alahmarimohammeds qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia
AT asirimuhannada qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia
AT alamrinoofm qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia
AT sarhanleena qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia
AT alkhashramishahads qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia
AT asiriabdullmgeeda qualityoflifeassessmentamongmultiplesclerosispatientsinsaudiarabia